Hence, the mitochondrial mechanisms through which MTFP1 ablation protects against hepatic steatosis appears to be functionally distinct from pathways currently being pursued as therapeutic interventions for MASLD and associated pathologies5,77,78. Here, MTFP1 is linked to fatty liver disease.